Recurrent Vaginal Cancer Completed Phase 1 Trials for Triapine (DB11940)

Also known as: Vaginal cancer recurrent / Cancer of vagina recurrent

IndicationStatusPhase
DBCOND0028818 (Recurrent Vaginal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00335998Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic MalignanciesTreatment